Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro

Coronary Artery Disease

Volumn 18, Issue 7, 2007, Pages 523-531

  Dopheide, Jörn F ^a   Sester, Urban ^b   Schlitt, Axel ^c   Horstick, Georg ^a   Rupprecht, Hans J ^a   Münzel, Thomas ^a   Blankenberg, Stefan ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Coronary artery disease; Dendritic cells; Immunology; Leucocytes

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA DR ANTIGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; T6 ANTIGEN;

ACUTE CORONARY SYNDROME; ARTICLE; ATHEROGENESIS; CELL COUNT; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENDRITIC CELL; FAMILY HISTORY; FLOW CYTOMETRY; HUMAN; HYPERLIPOPROTEINEMIA; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; STABLE ANGINA PECTORIS; UPREGULATION;

AGED; ANTIGENS, CD40; ANTIGENS, CD80; ANTIGENS, CD86; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CELL DIFFERENTIATION; CORONARY ARTERY DISEASE; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; MONOCYTES; RISK FACTORS;

EID: 35048850411     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3282eff1ad     Document Type: Article

References (34)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Hansson GK. Regulation of immune mechanisms in atherosclerosis. Ann N Y Acad Sci 2001; 947:157-165.
3. Hansson GK, Libby P, Schönbeck U, Yan ZQ. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91:281-291.
4. Bobryshev YV, Lord RSA. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in arthero-resistant and arthero-prone areas of the normal aorta. Arch Histol Cytol 1995; 58:307-322.
5. Millonig G, Niederegger H, Rabl W, Hochleitner BW, Hoefer D, Romani N, et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 2001; 21:503-508.
6. Steinman RM, Cohn ZA. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 1973; 137:1142-1462.
7. Strunk D, Rappersberger K, Egger C, Strobl H, Kromer E, Maurer D, et al. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells. Blood 1996; 87:1292-1302.
8. Zhou LJ, Tedder TF. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci 1996; 93:2588-2592.
9. Lotze MT, Thomson AW. Dendritic cells: biology and clinical applications. San Diego: Academic press; 2001.
10. Ni K, O'Neill HC. The role of dendritic cells in T-cell activation. Immunol Cell Biol 1997; 75:223-230.
11. Alderman CJJ, Bunyarad R, Chain BM, Foreman JC, Leake DS, Katz DR. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic microenvironment. Cardiovasc Res 2002; 55:806-819.
12. Perrin-Cocon L, Coutant F, Agaugue S, Deforges S, Andre P, Lotteau V. Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol 2001; 167:3785-3791.
13. Aicher A, Heeschen C, Mohaupt M, Cooke JP, Zeiher A, Dimmeler S. Nicotine strongly activates dendritic cell-mediated adaptive immunity. Potential role for progression of atherosclerotic lesions. Circulation 2003; 107:604-611.
14. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on Dendritic cells triggers production of high levels of levels of IL-12 and enhances T-cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184:747-752.
15. Blankenberg S, Tiret L, Bickel C, Peetz D, Cambien F, Meyer J, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002; 106:24-30.
16. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, et al. Generation of mature dendritic cells from human blood: an improved method with special regard to clinical application. J Immunol Methods 1996; 196:137-151.
17. Herbst B, Köhler G, Mackensen A, Veelken H, Mertelsmann R, Lindemann A. CD34+ peripheral blood progenitor cells and monocyte derived dendritic cells: a comparative analysis. Brit J Haematol 1997; 99:490-499.
18. Millonig G, Schwentner C, Mueller P, Mayerl C, Wick G. The vascular-associated lymphoid tissue: a new site of local immunity. Curr Opin Lipidol 2001; 12:547-553.
19. Bobryshev YV, Lord RSA. Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local-inflammatory reactions. Cardiovasc Res 1998; 37:799-810.
20. Bobryshev YV. Dendritic cells and their involvement in atherosclerosis. Curr Opin Lipidol 2000; 11:511-517.
21. Yilmaz A, Weber J, Cicha I, Stumpf C, Klein M, Raithel D, et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J Am Coll Cardiol 2006; 48:70-80.
22. Van Vre EA, Hoymans VY, Bult H, Lenjou M, Van Bockstaele DR, Vrints CJ, et al. Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. Coron Artery Dis 2006; 17:243-248.
23. Cao W, Bobryshev YV, Lord RSA, Oakley REI, Lee SH, Lu J. Dendritic cells in the arteria wall express C1q: potential significance in atherogenesis. Cardiovasc Res 2003; 60:175-186.
24. Schwaeble W, Schafer MK, Petry F. Follicular dendritic cells, interdigitating, and cells of the monocyte-macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis. J Immunol 1995; 155:4971-4978.
25. Belge KU, Dayyani F, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J Immunol 2002; 168:3536-3542.
26. Ziegler-Heitbrock HW, Fingerle G, Strobel M, Schraut W, Stelter F, Schutt C, et al. The novel subset of CD14+/CD16+ blood monocytes exhibits features of tissue macrophages. Eur J Immunol 1993; 23:2053-2058.
27. Acunta P, Weiss L, Haeffner-Cavaillon N. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur J Immunol 2000; 30:1872-1883.
28. Randolph GJ, Sanchez-Schmitz G, Liebman RM, Schakel K. The CD16+ (FcgammaRIII+) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue setting. J Exp Med 2002; 196:517-527.
29. Schlitt A, Heine G, Blankenberg S, Dopheide JF, Lackner KJ, Iz M, et al. CD14+CD16+ Monocytes are a risk factor for coronary artery disease and related to serum TNF-a-levels. Thromb Haemost 2004; 92:419-424.
30. De Backer J, Mark R, De Bacquer D, Van Renterghem L, Verbraekel E, Kornitzer M, et al. Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis 2002; 160:457-463.
31. Yang Y, Wilson JM. CD40 ligand dependent T-cell activation: requirement of B7-CD28 signaling through CD40. Science 1996; 273:1862-1864.
32. Grewal IS, Foellmer HG, Grewal KG, Xu J, Hardardottir F, Baron JL, et al. Requirement for CD40 ligand in costimulation induction, T-cell activation and experimental allergic encephalomyelitis. Science 1996; 273:1864-1867.
33. Sun D, Fernandes G. Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production. Cell Immunol 2003; 223:52-62.
34. Yilmaz A, Reiss C, Omeima T, Weng A, Stumpf C, Raaz D, et al. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. Atherosclerosis 2004; 172:85-93.